Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 55Terminated 17Recruiting 5Unknown 4Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia 1Burkitt Lymphoma 1

Interventions

Azacitidine 39Cytarabine 38venetoclax 34fludarabine 29Cyclophosphamide 21Daunorubicin 19fludarabine phosphate 18Decitabine 17Specimen Handling 15Tacrolimus 14Busulfan 14Injections 12Granulocyte Colony-Stimulating Factor 12Biopsy 12Mycophenolic Acid 11Melphalan 11Idarubicin 10Etoposide 10CPX-351 10Whole-Body Irradiation 9Stem Cell Transplantation 9Mitoxantrone 8decitabine and cedazuridine drug combination 7Thiotepa 7Peripheral Blood Stem Cell Transplantation 7ivosidenib 6enasidenib 6Methotrexate 6Filgrastim 6gilteritinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myeloid, Acute × Clofarabine × Clear all
NCT04994808 2026-01-26

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
23 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡